Helicos BioSciences Announces the Sale of a Helicos(R) Genetic Analysis System to the Turku Centre for Biotechnology
CAMBRIDGE, Mass., Jan 19, 2010 -- Helicos BioSciences Corporation (NASDAQ: HLCS), today announced the sale of a Helicos(R) Genetic Analysis System to the Turku Centre for Biotechnology in Turku, Finland. The center, led by Dr. Riitta Lahesmaa, is a joint facility of the University of Turku and Åbo Akademi University.
"We are very excited by our acquisition of a Helicos System, as it will allow us to perform novel experiments using single molecule sequencing technology." said Riitta Lahesmaa, Director of the center.
"We are delighted to have the Turku Center as a customer. Their scientists appreciate the unique benefits of having single molecule analysis capability and we look forward to their efforts in generating breakthrough discoveries using Helicos technology." stated Ron Lowy, Helicos Chief Executive Officer.
The Turku Center sale represents the 10th sale of a HeliScope(TM) Single Molecule Sequencer.
To date, 12 Helicos Systems are installed and operating at customer sites at key national and international institutions with an additional, previously announced purchased system, waiting for site preparations to be completed.
"We began 2009 with one Helicos System installed at a customer site. By placing an average of one system per month during 2009, culminating with our latest order from Turku, we have achieved a solid customer base using our technology. We believe that these systems, as well as new systems from additional sales, will generate important scientific data that will lead to new and unique applications, and, ultimately, revolutionary scientific breakthroughs." said Lowy.
The Helicos Genetic Analysis System is the world's first and only commercially available, single molecule sequencing technology, and enables scientists to conduct revolutionary studies in the fields of genome biology, cancer research, common diseases, and microbiology without DNA ligation or amplification. Genetic analysis with Helicos' technology eliminates the biases, complexity and errors introduced by DNA amplification, requires minute amounts of starting material, is amenable to the analysis of degraded nucleic acids, and provides the most direct and accurate view of biological samples.
About the Turku Centre for Biotechnology:
Turku Centre for Biotechnology was established in 1989 and is an institute of University of Turku and Åbo Akademi University. The Centre facilitates biotechnology and biomedical research and scientific interactions between research groups across departments and within the two universities, and provides technical expertise and coordinating services for academic and industrial projects in several central areas of biotechnology. Many of the key instruments have been installed at the Centre to create "core facilities" for biotechnical research. The Centre has also provided a forum for active interactions between academia and industry. Such interactions have resulted in a number of biotech companies, which are based on scientific discoveries in academia. www.btk.fi